Immunofluorescence staining confirmed the decreased levels of CD44 and pSTAT3 in DCIS-shCD44 xenograft tumors compared to DCIS-shLuc xenograft tumors (Fig. 5E). The gene discussed is CD44; the disease is ductal breast carcinoma in situ.